1. Home
  2. PMM vs OABI Comparison

PMM vs OABI Comparison

Compare PMM & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Putnam Managed Municipal Income Trust

PMM

Putnam Managed Municipal Income Trust

HOLD

Current Price

$6.23

Market Cap

258.7M

Sector

Finance

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.46

Market Cap

225.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMM
OABI
Founded
1989
2012
Country
United States
United States
Employees
N/A
89
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.7M
225.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PMM
OABI
Price
$6.23
$1.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
111.4K
253.6K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
4.68%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$52.42
Revenue Next Year
N/A
$64.69
P/E Ratio
$27.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.70
$1.22
52 Week High
$6.52
$2.22

Technical Indicators

Market Signals
Indicator
PMM
OABI
Relative Strength Index (RSI) 54.06 29.50
Support Level $6.07 $1.32
Resistance Level $6.36 $1.86
Average True Range (ATR) 0.09 0.08
MACD 0.02 -0.01
Stochastic Oscillator 83.74 0.00

Price Performance

Historical Comparison
PMM
OABI

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: